A Double Blind Randomized Controlled Trial to Assess the Efficacy and Safety of a Quadruple Ultra-low-dose Treatment for Hypertension (QUARTETUSA-BioLINCC)
Getting access
No access information recorded yet.
About this database
| Last updated | 2026-08-25 |
|---|